ANNEXON INC. - COMMON

Annexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4)

16 4 2024 16:05:00 提供 Nasdaq GlobeNewswire

Annexon Biosciences to Present at the 23rd Annual Needham Virtual Healthcare Conference

03 4 2024 08:00:00 提供 Nasdaq GlobeNewswire

Annexon Reports Fourth Quarter and Year-End 2023 Financial Results and Key Anticipated Milestones

26 3 2024 16:05:00 提供 Nasdaq GlobeNewswire

Annexon Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(c)(4)

18 3 2024 16:05:00 提供 Nasdaq GlobeNewswire

Annexon Biosciences to Present at the TD Cowen 44th Annual Health Care Conference

27 2 2024 08:00:00 提供 Nasdaq GlobeNewswire

Annexon to Host Virtual R&D Day on Guillain-Barré Syndrome, Focusing on its Serious Unmet Need and Annexon’s Novel Therapeutic Approach

21 2 2024 08:00:00 提供 Nasdaq GlobeNewswire

Annexon Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(c)(4)

20 2 2024 16:05:00 提供 Nasdaq GlobeNewswire

Annexon Outlines 2024 Priorities with Late-Stage Clinical Milestones Across Upstream Complement Portfolio for Autoimmune, Ophthalmic and Neurodegenerative Diseases

07 1 2024 20:00:05 提供 Nasdaq GlobeNewswire

Annexon Biosciences to Present at the 42nd Annual J.P. Morgan Healthcare Conference

27 12 2023 06:30:00 提供 Nasdaq GlobeNewswire

Annexon Announces Pricing of $125.0 Million Underwritten Public Offering of Common Stock

20 12 2023 17:27:50 提供 Nasdaq GlobeNewswire

Annexon Outlines Global Registrational Program for ANX007 in Geographic Atrophy with FDA Alignment on Vision Preservation as Primary Endpoint

20 12 2023 17:10:53 提供 Nasdaq GlobeNewswire

Annexon Reports Phase 1 Results for ANX1502, its Oral Small Molecule Inhibitor of the Classical Complement Pathway

20 12 2023 17:08:02 提供 Nasdaq GlobeNewswire

Annexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4)

18 12 2023 16:01:00 提供 Nasdaq GlobeNewswire

Annexon Biosciences to Participate in the 6th Annual Evercore ISI HealthCONx Conference

22 11 2023 16:01:00 提供 Nasdaq GlobeNewswire

Annexon Reports Significant Progress with its Priority Programs and Third Quarter 2023 Financial Results

13 11 2023 06:30:00 提供 Nasdaq GlobeNewswire

Annexon Biosciences to Participate in 2023 Jefferies London Healthcare Conference

09 11 2023 06:30:00 提供 Nasdaq GlobeNewswire

Annexon Receives PRIME Designation from the EMA for ANX007 for the Treatment of Geographic Atrophy

24 10 2023 06:30:00 提供 Nasdaq GlobeNewswire

Annexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4)

18 10 2023 16:01:00 提供 Nasdaq GlobeNewswire

Annexon Announces Clinical and Regulatory Progress for ANX005 Pivotal Program in Guillain-Barré Syndrome (GBS)

10 10 2023 06:30:00 提供 Nasdaq GlobeNewswire

Annexon Biosciences to Participate in the 2023 Cantor Global Healthcare Conference

19 9 2023 06:30:00 提供 Nasdaq GlobeNewswire